Blood Supply: Scotland has issued its first amber alert for critically low blood stocks, with Group O supplies falling below two days’ worth at times. Hospitals will be asked to reserve Type O for essential use from Nov. 10 as officials urge people to donate. Ebola Response: A British doctor infected in the Democratic Republic of Congo is being treated in isolation at London’s Royal Free Hospital. Health officials say the risk to the public is low. Drug Manufacturing: Biocodex will invest €15 million in a French facility to manufacture microbiome-based medicines, partnering with Belgium’s MRM Health to develop production capacity for clinical and potential commercial supply. Maternal Health: UNICEF and Canada are backing training for health workers in Nigeria’s Bauchi State to prevent and manage postpartum haemorrhage, a leading cause of maternal deaths. Medicine Safety: Kenya’s pharmacists warn against inserting oral antihistamine tablets vaginally, saying the unapproved practice can cause irritation and tissue injury.